CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Open-market sale See remarks sold 1,621 shares at $6.06 ($9,823)
- 4 Planned sale Chief Financial Officer sold 9,102 shares at an average $6.03 ($54,905)
- 4 Open-market sale President, R&D sold 2,688 shares at $6.06 ($16,289)
- 4 Open-market sale Chief Legal Officer sold 1,632 shares at $6.06 ($9,890)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale See remarks sold 245 shares at $7.51 ($1,840)
- 4 Planned sale Chief Financial Officer sold 6,457 shares at an average $7.46 ($48,184)
- 4 Open-market sale President, R&D sold 648 shares at $7.51 ($4,866)
- 4 Open-market sale Chief Legal Officer sold 295 shares at $7.51 ($2,215)
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- S-3ASR Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chief Financial Officer sold 10,780 shares at an average $8.56 ($92,316)
- 4 Planned sale See remarks sold 42,359 shares at an average $8.34 ($353,071)
Page 10 of 28 · 556 filings